STEFANIE SHIRE: Open Payments
NPI 1902119159 · LAGRANGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 42 payments from 18 companies in 2025. Trend: 2023 $499 · 2024 $564 · 2025 $718
Food & beverage: $718
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $182 |
| ABBVIE INC. | 5 | $79 |
| Novo Nordisk Inc | 4 | $65 |
| Astellas Pharma US Inc | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Boston Scientific Corporation | 1 | $25 |
| Verona Pharma, Inc. | 1 | $23 |
Products named: PREVNAR 20, VRAYLAR, VYNDAQEL, Veozah, FARXIGA, Auvelity, MOUNJARO, Kerendia.
Industry payments across IN — which companies pay providers there.
